Found 1856 results for "cancer"
Large observational cohorts consistently link GLP-1 receptor agonist (GLP-1RA) exposure — drugs like semaglutide and liraglutide — to 7–30% relative risk…
Understanding why the immune system fails to eliminate tumors is one of cancer biology's central puzzles — and a new molecular mechanism may help explain how…
Understanding why some cancers resist their own programmed destruction has long been central to improving immunotherapy outcomes. A new mechanism — one…
Drug resistance remains the dominant reason curative intent fails in head and neck squamous cell carcinoma (HNSCC), one of the most lethal and disfiguring…
When cells run low on energy, their survival depends on rapidly upshifting glucose metabolism — and how they orchestrate that response at the molecular level…
Cancer prevention is rarely framed as a competition problem, yet emerging theoretical biology suggests that how quickly healthy cells divide may be as…
The immune system's ability to recognize and destroy cancer cells depends heavily on the molecular signals that summon and activate the right defenders. A…
Understanding how cells first sense viral invasion has long been a central puzzle in immunology — and the answer has significant implications for antiviral…
Understanding why some immune responses against tumors succeed while others stall has been a central challenge in cancer immunology. A newly characterized…
The idea that what we eat could directly reshape whether our immune cells recognize tumors or clear viruses has long been an aspirational concept in…
The inheritance of healthy aging may be more powerful — and more measurable — than previously appreciated. Most longevity research focuses on centenarians…
For the millions of adults living with fatty liver disease, the absence of cirrhosis has long been mistakenly equated with low cancer risk. This large-scale…
For patients who survive one blood cancer, the specter of a second one — triggered by the very therapies that kept them alive — represents one of oncology's…
Cancer rates among firefighters remain disproportionately high compared with the general population, yet the precise chemical exposures driving that risk have…
Pancreatic cancer remains one of oncology's most intractable challenges — five-year survival rates hover near 12% — partly because existing prognostic tools…
For the roughly 15% of breast cancer patients diagnosed with triple-negative disease — the subtype with the fewest targeted treatment options and highest…
The first thousand days of life may be among the most consequential nutritional windows a human ever passes through — and most people never get to choose what…
Understanding how cells detect and respond to calcium depletion inside the endoplasmic reticulum has profound implications for immune function, muscle…
Liver fibrosis kills tens of thousands annually and has no approved cure — a deficit partly explained by how fibrotic tissue actively shields itself from…
Decades after diethylstilbestrol (DES) was pulled from clinical use, its molecular legacy continues to inform how scientists think about endocrine disruption…